English
| Part Number: | MAX30003CTI+T |
|---|---|
| Manufacturer/Brand: | Analog Devices Inc./Maxim Integrated |
| Part of Description: | IC ECG FRONT END 28TQFN |
| Datasheets: |
|
| RoHs Status: | ROHS3 Compliant |
| Payment: | PayPal / Credit Card / T/T |
| Shipment Way: | DHL / Fedex / TNT / UPS / EMS |
| Share: |
Ship From: Hong Kong
| Quantity | Unit Price |
|---|---|
| 1+ | $13.5135 |
Online RFQ submissions: Fast responses, Better prices!
| Product Attribute | Attribute Value |
|---|---|
| Type | ECG Front End |
| Supplier Device Package | 28-TQFN (5x5) |
| Series | - |
| Package / Case | 28-WFQFN Exposed Pad |
| Product Attribute | Attribute Value |
|---|---|
| Package | Tape & Reel (TR) |
| Mounting Type | Surface Mount |
| Base Product Number | MAX30003 |
| Applications | Heart Rate Monitoring |




The MAX30003CTI+T by Analog Devices Inc./Maxim Integrated stands out as an ultra-low power, single-channel biopotential analog front end (AFE) specifically designed for compact and battery-sensitive electrocardiogram (ECG) applications. It is engineered to deliver clinical-grade ECG measurements and integrated heart rate detection, ideal for next-generation medical, wearable, and fitness products. For design engineers and procurement teams targeting event monitors, single-lead patches, or portable ECG solutions, the MAX30003CTI+T offers an optimized balance of high performance, low noise, and power efficiency in a convenient 28-TQFN (5x5mm) package.
At the heart of its appeal, the MAX30003CTI+T integrates several innovations to maximize signal fidelity and longer operational lifetimes in wearable and point-of-care settings. Key design aspects include:
A fully differential input structure with an impressive common-mode rejection ratio (CMRR) greater than 100dB, ensuring accurate biopotential signal acquisition in noisy electrical environments.
High input impedance (>500MΩ), which minimizes signal loss due to electrode and skin impedance variances, particularly beneficial during 'dry starts' or when electrodes are not optimally connected.
Low input-referred noise (5µVp-p over 0.05–150Hz, typical), supporting the capture of low-amplitude physiological signals.
ESD protection (up to ±15kV air-gap, ±8kV contact discharge), EMI filtering, and advanced input multiplexing.
A programmable gain stage, various analog and digital filter options (including high-pass, low-pass, and FIR/IIR blocks), and a high-resolution (18-bit) sigma-delta ADC.
Robust ultra-low power operation, with supply currents as low as 76µA (ECG channel active at 1.1V) and shutdown current down to sub-2.5µA, making it suitable for single coin cell battery-powered wearable devices.
Among system-level features, the MAX30003CTI+T integrates leads-on/off detection, built-in calibration voltages for self-test routines, and fast recovery from overdrive conditions—key for robust operations during events such as defibrillation or electrosurgery. The heart rate algorithm, R-to-R interval detection, FIFO memory, and interrupt-driven SPI interface contribute to flexible, low-duty-cycle host wakeup scenarios, enabling further energy savings.
Engineers evaluating the MAX30003CTI+T must consider several metrics central to system optimization:
Supply and Interface:
Supports analog and digital supply voltages from 1.1V to 2.0V, and an interface supply up to 3.6V for flexible system integration.
Compatible with standard SPI (up to 12MHz), minimizing processor overhead with FIFO buffering (32 words).
Signal Chain:
Differential input dynamic range up to ±32.5mVp-p (at 1.8V supply), with a DC offset tolerance up to ±650mV. This flexibility supports a range of electrode types and configurations.
Programmable ADC sample rates from 125SPS to 512SPS, addressing both high-resolution monitoring and battery-life-optimized, low-data-rate applications.
Total harmonic distortion is kept below 0.3% (typical), across supported input and offset conditions.
Ultra-high DC common-mode input impedance (45GΩ) and differential input impedance (1.5GΩ) help preserve signal integrity.
Power and Environmental:
Channel operating current as low as 76µA to 109µA, depending on voltage supply; deep sleep/shutdown mode further reduces consumption.
Operating temperature range from 0°C to +70°C covers most portable and clinical application scenarios.
RoHS 3.0 compliant, with an MSL (Moisture Sensitivity Level) rating of 1 (unlimited floor life).
The MAX30003CTI+T is not only technically capable but also application-aware, providing integrated solutions to ECG system-level challenges:
High-real-world common-mode rejection and input impedance ensure reliable operation even in dry or high-motion conditions, which is vital for consumer wearables or ambulatory monitors where electrode detachment and noise are constant risks.
Built-in lead-on/off detection (down to 0.7μA typ. lead-on detect current), programmable calibration support, and fault detection ensure the module can support FDA and IEC regulatory test requirements in final medical device assemblies.
The AFE's robust input architecture, fast-recovery operation, and support for high electrode offset voltages allow safe operation amidst transient artifacts, such as during patient physical motion, shock, or use with diverse electrode materials.
On-chip heart rate and R-to-R detection algorithms, along with interrupt-driven notification and configurable data buffering, offload the host microcontroller, minimizing main processor wakeup cycles and reducing overall system power budget.
For engineers seeking example use cases, the MAX30003CTI+T readily addresses single-lead event monitors for arrhythmia detection, wireless ECG patches for home or clinical environments, chestband fitness monitors, and bio-authentication devices that require on-demand, high-accuracy ECG capture.
Mechanical and environmental robustness are addressed through a space-saving 28-WFQFN (5x5mm) exposed pad package, well-suited for high-density PCB layouts mandatory in modern wearables. Thermal characteristics, with a junction-to-ambient thermal resistance of 29°C/W, provide reliable passive cooling in ultra-compact enclosures. The device’s environmental certifications—including RoHS 3 compliance and REACH unaffected status—further simplify design cycles for global regulatory approvals. ESD tolerance up to ±15kV (air-gap) and ±8kV (contact discharge) surpasses typical IEC61000-4-2 Level 4 requirements for medical electronics, enhancing reliability during electrode attachment/detachment cycles and during field use.
When considering design alternatives or future-proofing procurement strategies, engineers should evaluate direct and system-level substitutes for the MAX30003CTI+T:
Analog Devices/Maxim Integrated’s MAX30001 or MAX30004: Both offer similar AFE architectures but may target different lead counts or add/remove features such as bioimpedance or multi-channel support.
Texas Instruments ADS1291/ADS1292: These multichannel biopotential AFEs offer comparable CMRR, input impedance, and power profiles, though may differ in package size and integration levels.
Analog Devices AD8232: A well-established, single-lead AFE suitable for constrained applications, though it may lack some of the advanced digital integration and ultra-low-power features found in the MAX30003CTI+T.
Selection requires careful verification of form factor, supply voltage compatibility, input/output interface, and regulatory test history, as even subtle platform differences can impact overall system design and certification flows.
The MAX30003CTI+T analog front end offers a compelling mix of clinical-grade precision, robust hardware design, and low-power application integration, tailored for the demands of modern wearable ECG and heart rate products. Its feature set, power profile, and configurability address the critical needs of both design engineers and procurement teams tasked with delivering reliable, market-ready biopotential sensing platforms. With strong alternatives available but rarely matching all integration and application features, the MAX30003CTI+T continues to set a benchmark for miniaturized, medical-grade ECG analog front ends in the portable health and fitness electronics market.
IC TRANSLTR BIDIRECTIONAL 20UCSP
MAXIM TSSOP20
1 LEAD ECG & BIOZ AFE
IC BIOPOTENTIAL AFE 30WLP
ECG AFE FEATHER BOARD
MAXIM 2018+RoHS
EVAL MAX30001 BIO AFE
MAX SSOP
IC AFE 1 CHAN 20BIT 30WLP
2 CHANNEL BIO Z
IC BIOPOTENTIAL AFE 30WLP
IC ECG FRONT END 30WLP
IC BIOPOTENTIAL AFE 30WLP
BIO POTENTIAL AFE
IC AFE 1 CHAN 20BIT 30WLP
BIO POTENTIAL AFE
IC TRANSLATOR BIDIR 20TSSOP
IC TRANSLATOR BIDIR 20TSSOP
IC BIOPOTENTIAL AFE 30WLP
May 12th, 2026
May 8th, 2026
April 28th, 2026
April 20th, 2026
April 17th, 2026
April 8th, 2026
March 31th, 2026
March 23th, 2026
March 20th, 2026
March 9th, 2026
March 4th, 2026
February 28th, 2026
February 3th, 2026
January 28th, 2026
January 19th, 2026
January 16th, 2026
January 9th, 2026
December 29th, 2025
December 25th, 2025
December 17th, 2025
December 10th, 2025
December 4th, 2025
November 25th, 2025
November 20th, 2025
November 11th, 2025
November 3th, 2025
October 30th, 2025
October 22th, 2025
October 16th, 2025
October 9th, 2025
September 28th, 2025
September 17th, 2025
September 9th, 2025
September 1th, 2025
August 25th, 2025
August 20th, 2025
July 3th, 2025
December 18th, 2024
June 21th, 2023
April 27th, 2023
July 1th, 2022
March 4th, 2021
September 10th, 2020
January 23th, 2020
0 Articles





June 5th, 2026
June 5th, 2026
June 5th, 2026
June 5th, 2026
MAX30003CTI+TAnalog Devices Inc./Maxim Integrated |
Quantity*
|
Target Price(USD)
|